Seeing Is Believing
Currently out of the existing stock ratings of Yale Jen, 21 are a BUY (100%).
Analyst Yale Jen, currently employed at LAIDLAW, carries an average stock price target met ratio of 40.48% that have a potential upside of 76.34% achieved within 300 days.
Yale Jen’s has documented 39 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SLNO, Soleno Therapeutics at 27-Mar-2025.
Analyst best performing recommendations are on CRIS (CURIS).
The best stock recommendation documented was for CRIS (CURIS) at 12/8/2020. The price target of $10 was fulfilled within 31 days with a profit of $3.45 (52.67%) receiving and performance score of 16.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$68
$58.89 (646.43%)
$72
1 months 1 days ago
(10-Mar-2025)
1/5 (20%)
$53.71 (375.86%)
75
Buy
$60
$50.89 (558.62%)
$63
1 months 4 days ago
(07-Mar-2025)
14/34 (41.18%)
$44.03 (275.70%)
165
Buy
1 months 4 days ago
(07-Mar-2025)
3/5 (60%)
$21.39 (65.59%)
559
Buy
$48
$38.89 (426.89%)
$40
1 years 2 months 3 days ago
(08-Feb-2024)
4/8 (50%)
$10.09 (26.62%)
195
Buy
$36
1 years 8 months 28 days ago
(14-Jul-2023)
2/2 (100%)
$15.83 (78.48%)
271
Which stock is Yale Jen is most bullish on?
What Year was the first public recommendation made by Yale Jen?